Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

5438 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders

Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB.

Cell Mol Neurobiol. 2022 Oct;42(7):2075-2095. doi: 10.1007/s10571-021-01093-4. Epub 2021 May 1.

0

0

0

PUBMED

Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective

Su LD, Wang N, Han J, Shen Y.

Neuroscientist. 2022 Oct;28(5):453-468. doi: 10.1177/10738584211021018. Epub 2021 Jun 4.

0

0

0

PUBMED

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

0

0

0

PUBMED

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Oikonomou P, Jost WH.

J Neural Transm (Vienna). 2022 Oct;129(10):1247-1256. doi: 10.1007/s00702-022-02529-x. Epub 2022 Jul 20.

0

0

0

PUBMED

CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics

Sen T, Thummer RP.

Neurotox Res. 2022 Oct;40(5):1597-1623. doi: 10.1007/s12640-022-00564-w. Epub 2022 Aug 31.

0

0

0

PUBMED

Endosomal recycling defects link Huntington's disease with McLeod syndrome

Marsan E, Huang EJ.

J Cell Biol. 2022 Oct 3;221(10):e202208164. doi: 10.1083/jcb.202208164. Epub 2022 Sep 16.

0

0

0

PUBMED

Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases

Bild W, Vasincu A, Rusu RN, Ababei DC, Stana AB, Stanciu GD, Savu B, Bild V.

Biomolecules. 2022 Oct 6;12(10):1429. doi: 10.3390/biom12101429.

0

0

0

PUBMED

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders

Baier A, Szyszka R.

Front Mol Biosci. 2022 Oct 6;9:916063. doi: 10.3389/fmolb.2022.916063. eCollection 2022.

0

0

0

PUBMED

Neuroprotective potential of Moringa oleifera mediated by NF-kB/Nrf2/HO-1 signaling pathway: A review

Mundkar M, Bijalwan A, Soni D, Kumar P.

J Food Biochem. 2022 Oct 7:e14451. doi: 10.1111/jfbc.14451. Online ahead of print.

0

0

0

PUBMED

Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review

Wang Q, Xue H, Yue Y, Hao S, Huang SH, Zhang Z.

Front Mol Neurosci. 2022 Oct 4;15:1014251. doi: 10.3389/fnmol.2022.1014251. eCollection 2022.

0

0

0

PUBMED

Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases

Zhang L, Liu Y, Lu Y, Wang G.

Biochem Pharmacol. 2022 Oct 12;206:115295. doi: 10.1016/j.bcp.2022.115295. Online ahead of print.

0

0

0

PUBMED

The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases

Liu H, Xu S, Wang C, Deng Y, Xu B, Yang T, Sun J, Liu W.

Neuroscience. 2022 Oct 3:S0306-4522(22)00491-2. doi: 10.1016/j.neuroscience.2022.09.021. Online ahead of print.

0

0

0

PUBMED

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

0

0

0

PUBMED

Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2

Egorova PA, Bezprozvanny IB.

Cerebellum. 2022 Oct;21(5):742-749. doi: 10.1007/s12311-021-01349-1. Epub 2022 Jan 3.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy